FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Davidson

Research Profile

Living Beings

Disorders

Pseudomembranous Enterocolitis

Chemicals & Drugs

Anatomy

Physiology

Procedures

Double-Blind Method

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Adam K Cheknis; Susan P Sambol; David Davidson; Kristin J Nagaro; Maria C Mancini; G Aida Hidalgo-Arroyo; Jon S Brazier; Stuart Johnson; Dale N Gerding
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.
Jennifer Peppe; Andrew Porzio; David Davidson
A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.
Judith A O'Brien; Betsy J Lahue; Jaime Caro; David Davidson
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Davidson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Adam K Cheknis; Susan P Sambol; David Davidson; Kristin J Nagaro; Maria C Mancini; G Aida Hidalgo-Arroyo; Jon S Brazier; Stuart Johnson; Dale N Gerding
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.
Anaerobe 2009;15(6):230-3.
2008: Jennifer Peppe; Andrew Porzio; David Davidson
A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.
British journal of clinical pharmacology 2008;66(1):102-9.
2007: Judith A O'Brien; Betsy J Lahue; Jaime Caro; David Davidson
The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007;28(11):1219-27.
2006: R H Barker; Rafif Dagher; David Davidson; Judith K Marquis
Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties.
Alimentary pharmacology & therapeutics 2006;24(11-12):1525-34.
2006: Thomas J Louie; Jennifer Peppe; C Kevin Watt; David Johnson; Rasheed Mohammed; Gordon Dow; Karl Weiss; Stuart Simon; Joseph F John; Gary Garber; Scott Chasan-Taber; David Davidson
Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(4):411-20.
2003: Andrew Cooper; Eric Johannsen; Seiji Maruo; Ellen Cahir-McFarland; Diego Illanes; David Davidson; Elliott Kieff
EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth.
Journal of virology 2003;77(2):999-1010.
2002: Dennis P Heller; Steven K Burke; David Davidson; Joanne M Donovan
Absorption of colesevelam hydrochloride in healthy volunteers.
The Annals of pharmacotherapy 2002;36(3):398-403.
2001: Donald B Hunninghake; William Insull; P Toth; David Davidson; Joanne M Donovan; Steven K Burke
Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively.
Atherosclerosis 2001;158(2):407-16.
2000: Ellen Cahir-McFarland; David Davidson; S L Schauer; J Duong; Elliott Kieff
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(11):6055-60.
1999: Kenneth M Kaye; Kenneth Izumi; H Li; Eric Johannsen; David Davidson; R Longnecker; Elliott Kieff
An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation.
Journal of virology 1999;73(12):10525-30.
1998: B S Sylla; S C Hung; David Davidson; Eudoxia G Hatzivassiliou; NL Malinin; David Wallach; T D Gilmore; Elliott Kieff; George Mosialos
Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(17):10106-11.
1995: Q Hu; David Davidson; Pamela L Schwartzberg; F Macchiarini; Michael J Lenardo; J A Bluestone; L A Matis
Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage.
The Journal of biological chemistry 1995;270(4):1928-34.
1993: H Y Park; David Davidson; Bruce M Raaka; Herbert H Samuels
The herpes simplex virus thymidine kinase gene promoter contains a novel thyroid hormone response element.
Molecular endocrinology (Baltimore, Md.) 1993;7(3):319-30.
1986: Jan Vilcek; A Klion; D Henriksen-DeStefano; A Zemtsov; David Davidson; M Davidson; A E Friedman-Kien; J Le
Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis.
Journal of clinical immunology 1986;6(2):146-51.